Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Symeon Metallidis and Haralampos Milionis.
Symeon Metallidis
Connection Strength
0.174
Haralampos Milionis
  1. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
    View in: PubMed
    Score: 0.060
  2. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
    View in: PubMed
    Score: 0.058
  3. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e2013136.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.